Wipro Positioned as a 'Leader' in Everest Group Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group presented a detailed assessment of 28 Business Process Services (BPS) providers featured on the Life Sciences Operations – Services PEAK Matrix® and Wipro is proud to be named a Leader.

“The life sciences industry has had to grapple with a changing landscape marked by the decentralization of clinical trials, the adoption of omnichannel engagements, and a growing demand for automation, particularly in pharmacovigilance. These shifts have prompted enterprises to seek external support,” said Lloyd Fernandes, Practice Director at Everest Group. “Wipro distinguishes itself with its robust pharmacovigilance and regulatory affairs expertise. It has strengthened its capabilities through partnerships, acquisitions, and workforce expansion. Wipro’s exceptional talent, relationship management, and innovation are key strength areas highlighted by clients, which have helped cement its status as a Leader in Everest Group's 2023 Life Sciences Operations PEAK Matrix® Assessment.”

Everest Group has called out the following points as Wipro’s key strengths:

• Wipro is continuously investing in technology (launched IntelliDoc, partnering with Navitas Lifesciences for technological solutions for safety database implementation, and developing automation tools for pharmacovigilance, clinical, and regulatory services) and process (QPPV, Biomapas – providing LPPV (Local PV and Regulatory responsible Person) service globally to enhance its LS offering.
• While Wipro has a strong pharmacovigilance portfolio, its other services (such as sales and marketing and regulatory affairs operations) are seeing increased traction in the market.
• Wipro's portfolio of clients comprises a strong mix of both biopharma and medical devices.
• Clients highlight its process/domain expertise, skilled talent pool, innovation, and relationship management as areas of key strengths.